Full name
"NUGAT" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,1 | 0 | -0,1 | -363,5 |
Gross profit (loss) | -0,1 | 0,1 | -0,1 | -147,9 |
EBITDA | -0,1 | 0 | -0,2 | -2197,5 |
Short time liabilities | 2 | 2,1 | 2,3 | 8,6 |
Other operating costs | 0,1 | 0,1 | 0,1 | 15,9 |
Equity capital | 1,7 | 1,9 | 1,8 | -6,4 |
Operating profit (EBIT) | -0,1 | -0 | -0,2 | -1229,3 |
Assets | 3,8 | 4,2 | 4,2 | 0,5 |
Net profit (loss) | -0,1 | 0,2 | -0,1 | -160,7 |
Cash | 0 | 0 | 0 | 41,8 |
Net income from sale | 10,5 | 12,3 | 13,2 | 7,2 |
Liabilities and provisions for liabilities | 2,1 | 2,3 | 2,4 | 6,3 |
Working assets | 3,7 | 4 | 4 | 1,1 |
Other income costs | 0 | 0 | 0 | -53,7 |
Depreciation | 0 | 0 | 0 | -16,2 |
% | % | % | p.p. | |
Profitability of capital | -4,4 | 10,6 | -6,8 | -17,4 |
Equity capital to total assets | 44,5 | 45,5 | 42,4 | -3,1 |
Gross profit margin | -0,7 | 1,2 | -0,5 | -1,7 |
EBITDA Margin | -1 | 0,1 | -1,5 | -1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 71 | 63 | 64 | 1 |
Current financial liquidity indicator | 1.7931543588638306 | 1.8695192337036133 | 1.740175724029541 | -0,2 |
Net dept to EBITDA | 0.17036966979503632 | -2.3583362102508545 | 0.1593986451625824 | 2,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane